Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Laura Christine Collins, M.D.

Title
Institution
Department
Address
Phone
Fax

Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
  1. Kim HJ, Dominici L, Rosenberg SM, Zheng Y, Pak LM, Poorvu PD, Ruddy KJ, Tamimi R, Schapira L, Come SE, Peppercorn J, Borges VF, Warner E, Vardeh H, Collins LC, Gaither R, King TA, Partridge AH. Surgical Treatment after Neoadjuvant Systemic Therapy in Young Women with Breast Cancer: Results from a Prospective Cohort Study. Ann Surg. 2020 Dec 23; Publish Ahead of Print. PMID: 33378304.
    Citations:    Fields:    
  2. Oh H, Yaghjyan L, Austin-Datta RJ, Heng YJ, Baker GM, Sirinukunwattana K, Vellal AD, Collins LC, Murthy D, Eliassen AH, Rosner BA, Tamimi RM. Early-life and adult adiposity, adult height, and benign breast tissue composition. Cancer Epidemiol Biomarkers Prev. 2020 Dec 07. PMID: 33288551.
    Citations:    Fields:    
  3. Pak LM, Gaither R, Rosenberg SM, Ruddy KJ, Tamimi RM, Peppercorn J, Schapira L, Borges VF, Come SE, Warner E, Snow C, Collins LC, King TA, Partridge AH. Tumor phenotype and concordance in synchronous bilateral breast cancer in young women. Breast Cancer Res Treat. 2020 Nov 26. PMID: 33242164.
    Citations:    Fields:    
  4. Sella T, Gelber SI, Poorvu PD, Kim HJ, Dominici L, Guzman-Arocho YD, Collins L, Ruddy KJ, Tamimi RM, Peppercorn JM, Schapira L, Borges VF, Come SE, Warner E, Snow C, Jakubowski DM, Russell CA, Winer EP, Rosenberg SM, Partridge AH. Response to neoadjuvant chemotherapy and the 21-gene Breast Recurrence Score test in young women with estrogen receptor-positive early breast cancer. Breast Cancer Res Treat. 2020 Nov 04. PMID: 33150547.
    Citations:    Fields:    
  5. Baker GM, Guzman-Arocho YD, Bret-Mounet VC, Torous VF, Schnitt SJ, Tobias AM, Bartlett RA, Fein-Zachary VJ, Collins LC, Wulf GM, Heng YJ. Testosterone therapy and breast histopathological features in transgender individuals. Mod Pathol. 2021 01; 34(1):85-94. PMID: 32939016.
    Citations:    Fields:    
  6. Kensler KH, Liu EZF, Wetstein SC, Onken AM, Luffman CI, Baker GM, Collins LC, Schnitt SJ, Bret-Mounet VC, Veta M, Pluim JPW, Liu Y, Colditz GA, Eliassen AH, Hankinson SE, Tamimi RM, Heng YJ. Automated Quantitative Measures of Terminal Duct Lobular Unit Involution and Breast Cancer Risk. Cancer Epidemiol Biomarkers Prev. 2020 Nov; 29(11):2358-2368. PMID: 32917665.
    Citations: 1     Fields:    
  7. Collins LC. Precision pathology as applied to breast core needle biopsy evaluation: implications for management. Mod Pathol. 2021 01; 34(Suppl 1):48-61. PMID: 32879415.
    Citations:    Fields:    
  8. McGee EE, Kim CH, Wang M, Spiegelman D, Stover DG, Heng YJ, Collins LC, Baker GM, Farvid MS, Schedin P, Jindal S, Tamimi RM, Eliassen AH. Erythrocyte membrane fatty acids and breast cancer risk by tumor tissue expression of immuno-inflammatory markers and fatty acid synthase: a nested case-control study. Breast Cancer Res. 2020 07 22; 22(1):78. PMID: 32698885.
    Citations:    Fields:    Translation:HumansCells
  9. Patel JM, Goss A, Garber JE, Torous V, Richardson ET, Haviland MJ, Hacker MR, Freeman GJ, Nalven T, Alexander B, Lee L, Collins LC, Schnitt SJ, Tung N. Retinoblastoma protein expression and its predictors in triple-negative breast cancer. NPJ Breast Cancer. 2020; 6:19. PMID: 32550264.
    Citations: 1     
  10. Patel JM, Goss A, Garber JE, Torous V, Richardson ET, Haviland MJ, Hacker MR, Freeman GJ, Nalven T, Alexander B, Lee L, Collins LC, Schnitt SJ, Tung N. Retinoblastoma protein expression and its predictors in triple-negative breast cancer. NPJ Breast Cancer. 2020 Jun 05; 6(1):19. PMID: 33579981.
    Citations:    
  11. Wetstein SC, Onken AM, Luffman C, Baker GM, Pyle ME, Kensler KH, Liu Y, Bakker B, Vlutters R, van Leeuwen MB, Collins LC, Schnitt SJ, Pluim JPW, Tamimi RM, Heng YJ, Veta M. Deep learning assessment of breast terminal duct lobular unit involution: Towards automated prediction of breast cancer risk. PLoS One. 2020; 15(4):e0231653. PMID: 32294107.
    Citations: 2     Fields:    Translation:Humans
  12. Kotsopoulos J, McGee EE, Lozano-Esparza S, Garber JE, Ligibel J, Collins LC, Polyak K, Brown M, Narod S, Tamimi RM, Eliassen AH. Premenopausal Plasma Osteoprotegerin and Breast Cancer Risk: A Case-Control Analysis Nested within the Nurses' Health Study II. Cancer Epidemiol Biomarkers Prev. 2020 06; 29(6):1264-1270. PMID: 32277005.
    Citations:    Fields:    
  13. Parsons HA, Rhoades J, Reed SC, Gydush G, Ram P, Exman P, Xiong K, Lo CC, Li T, Fleharty M, Kirkner GJ, Rotem D, Cohen O, Yu F, Fitarelli-Kiehl M, Leong KW, Hughes ME, Rosenberg SM, Collins LC, Miller KD, Blumenstiel B, Trippa L, Cibulskis C, Neuberg DS, DeFelice M, Freeman SS, Lennon NJ, Wagle N, Ha G, Stover DG, Choudhury AD, Getz G, Winer EP, Meyerson M, Lin NU, Krop I, Love JC, Makrigiorgos GM, Partridge AH, Mayer EL, Golub TR, Adalsteinsson VA. Sensitive Detection of Minimal Residual Disease in Patients Treated for Early-Stage Breast Cancer. Clin Cancer Res. 2020 06 01; 26(11):2556-2564. PMID: 32170028.
    Citations: 1     Fields:    
  14. Rath M, Li Q, Li H, Lindström S, Miron A, Miron P, Dowton AA, Meyer ME, Larson BG, Pomerantz M, Seo JH, Collins LC, Vardeh H, Brachtel E, Come SE, Borges V, Schapira L, Tamimi RM, Partridge AH, Freedman M, Ruddy KJ. Correction: Evaluation of significant genome-wide association studies risk-SNPs in young breast cancer patients. PLoS One. 2020; 15(3):e0230529. PMID: 32163513.
    Citations:    Fields:    
  15. Pareja F, da Silva EM, Frosina D, Geyer FC, Lozada JR, Basili T, Da Cruz Paula A, Zhong E, Derakhshan F, D'Alfonso T, Wen HY, Giri DD, Hayes MM, Krings G, Bhargava R, Palazzo JP, Rakha EA, Hoda SA, Sanders ME, Collins LC, Schnitt SJ, Chen YY, Weigelt B, Jungbluth AA, Reis-Filho JS, Brogi E. Immunohistochemical analysis of IDH2 R172 hotspot mutations in breast papillary neoplasms: applications in the diagnosis of tall cell carcinoma with reverse polarity. Mod Pathol. 2020 06; 33(6):1056-1064. PMID: 31896809.
    Citations: 4     Fields:    
  16. Charlton BM, Farland LV, Boehmer U, Tamimi RM, Collins LC, VanKim NA, Bertone-Johnson ER, Potter J, Sarda V, Austin SB. Sexual orientation and benign breast disease in a cohort of U.S. women. Cancer Causes Control. 2020 Feb; 31(2):173-179. PMID: 31894493.
    Citations:    Fields:    Translation:Humans
  17. Poorvu PD, Gelber SI, Rosenberg SM, Ruddy KJ, Tamimi RM, Collins LC, Peppercorn J, Schapira L, Borges VF, Come SE, Warner E, Jakubowski DM, Russell C, Winer EP, Partridge AH. Prognostic Impact of the 21-Gene Recurrence Score Assay Among Young Women With Node-Negative and Node-Positive ER-Positive/HER2-Negative Breast Cancer. J Clin Oncol. 2020 03 01; 38(7):725-733. PMID: 31809240.
    Citations: 3     Fields:    Translation:Humans
  18. Kensler KH, Poole EM, Heng YJ, Collins LC, Glass B, Beck AH, Hazra A, Rosner BA, Eliassen AH, Hankinson SE, Winer EP, Brown M, Tamimi RM. Androgen Receptor Expression and Breast Cancer Survival: Results From the Nurses' Health Studies. J Natl Cancer Inst. 2019 07 01; 111(7):700-708. PMID: 30445651.
    Citations: 7     Fields:    Translation:Humans
  19. Rath M, Li Q, Li H, Lindström S, Miron A, Miron P, Dowton AE, Meyer ME, Larson BG, Pomerantz M, Seo JH, Collins LC, Vardeh H, Brachtel E, Come SE, Borges V, Schapira L, Tamimi RM, Partridge AH, Freedman M, Ruddy KJ. Evaluation of significant genome-wide association studies risk - SNPs in young breast cancer patients. PLoS One. 2019; 14(5):e0216997. PMID: 31125336.
    Citations: 1     Fields:    Translation:Humans
  20. Fortner RT, Sisti J, Chai B, Collins LC, Rosner B, Hankinson SE, Tamimi RM, Eliassen AH. Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' Health Studies. Breast Cancer Res. 2019 03 12; 21(1):40. PMID: 30867002.
    Citations: 4     Fields:    Translation:Humans
  21. Kensler KH, Sankar VN, Wang J, Zhang X, Rubadue CA, Baker GM, Parker JS, Hoadley KA, Stancu AL, Pyle ME, Collins LC, Hunter DJ, Eliassen AH, Hankinson SE, Tamimi RM, Heng YJ. PAM50 Molecular Intrinsic Subtypes in the Nurses' Health Study Cohorts. Cancer Epidemiol Biomarkers Prev. 2019 04; 28(4):798-806. PMID: 30591591.
    Citations: 6     Fields:    Translation:Humans
  22. Punglia RS, Bifolck K, Golshan M, Lehman C, Collins L, Polyak K, Mittendorf E, Garber J, Hwang SE, Schnitt SJ, Partridge AH, King TA. Epidemiology, Biology, Treatment, and Prevention of Ductal Carcinoma In Situ (DCIS). JNCI Cancer Spectr. 2018 Nov; 2(4):pky063. PMID: 30627695.
    Citations: 1     
  23. Rice MS, Tamimi RM, Bertrand KA, Scott CG, Jensen MR, Norman AD, Visscher DW, Chen YY, Brandt KR, Couch FJ, Shepherd JA, Fan B, Wu FF, Ma L, Collins LC, Cummings SR, Kerlikowske K, Vachon CM. Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics. Breast Cancer Res Treat. 2018 Jul; 170(1):129-141. PMID: 29502324.
    Citations: 4     Fields:    Translation:Humans
  24. Collins LC. Breast Pathology. Surg Pathol Clin. 2018 Mar; 11(1):i. PMID: 29413662.
    Citations:    
  25. Collins LC. Contemporary Topics in Breast Pathology. Surg Pathol Clin. 2018 Mar; 11(1):ix. PMID: 29413665.
    Citations:    Fields:    Translation:Humans
  26. Collins LC. Precursor Lesions of the Low-Grade Breast Neoplasia Pathway. Surg Pathol Clin. 2018 Mar; 11(1):177-197. PMID: 29413656.
    Citations: 2     Fields:    Translation:Humans
  27. Oh H, Eliassen AH, Beck AH, Rosner B, Schnitt SJ, Collins LC, Connolly JL, Montaser-Kouhsari L, Willett WC, Tamimi RM. Breast cancer risk factors in relation to estrogen receptor, progesterone receptor, insulin-like growth factor-1 receptor, and Ki67 expression in normal breast tissue. NPJ Breast Cancer. 2017; 3:39. PMID: 28979927.
    Citations: 6     
  28. Healey MA, Hirko KA, Beck AH, Collins LC, Schnitt SJ, Eliassen AH, Holmes MD, Tamimi RM, Hazra A. Assessment of Ki67 expression for breast cancer subtype classification and prognosis in the Nurses' Health Study. Breast Cancer Res Treat. 2017 Nov; 166(2):613-622. PMID: 28791482.
    Citations: 3     Fields:    Translation:Humans
  29. Collins LC, Witte TG, Silverman R, Green DB, Gomes KK. Imaging quasiperiodic electronic states in a synthetic Penrose tiling. Nat Commun. 2017 06 22; 8:15961. PMID: 28639623.
    Citations: 2     Fields:    
  30. Irshad H, Oh EY, Schmolze D, Quintana LM, Collins L, Tamimi RM, Beck AH. Crowdsourcing scoring of immunohistochemistry images: Evaluating Performance of the Crowd and an Automated Computational Method. Sci Rep. 2017 02 23; 7:43286. PMID: 28230179.
    Citations: 8     Fields:    Translation:Humans
  31. Torous VF, Schnitt SJ, Collins LC. Benign breast lesions that mimic malignancy. Pathology. 2017 Feb; 49(2):181-196. PMID: 28069257.
    Citations: 4     Fields:    Translation:HumansAnimals
  32. Heng YJ, Lester SC, Tse GM, Factor RE, Allison KH, Collins LC, Chen YY, Jensen KC, Johnson NB, Jeong JC, Punjabi R, Shin SJ, Singh K, Krings G, Eberhard DA, Tan PH, Korski K, Waldman FM, Gutman DA, Sanders M, Reis-Filho JS, Flanagan SR, Gendoo DM, Chen GM, Haibe-Kains B, Ciriello G, Hoadley KA, Perou CM, Beck AH. The molecular basis of breast cancer pathological phenotypes. J Pathol. 2017 Feb; 241(3):375-391. PMID: 27861902.
    Citations: 23     Fields:    Translation:Humans
  33. Oh H, Eliassen AH, Wang M, Smith-Warner SA, Beck AH, Schnitt SJ, Collins LC, Connolly JL, Montaser-Kouhsari L, Polyak K, Tamimi RM. Expression of estrogen receptor, progesterone receptor, and Ki67 in normal breast tissue in relation to subsequent risk of breast cancer. NPJ Breast Cancer. 2016; 2. PMID: 28111631.
    Citations: 11     
  34. Ahern TP, Beck AH, Rosner BA, Glass B, Frieling G, Collins LC, Tamimi RM. Continuous measurement of breast tumour hormone receptor expression: a comparison of two computational pathology platforms. J Clin Pathol. 2017 May; 70(5):428-434. PMID: 27729430.
    Citations: 3     Fields:    Translation:Humans
  35. Farland LV, Tamimi RM, Eliassen AH, Spiegelman D, Collins LC, Schnitt SJ, Missmer SA. A prospective study of endometriosis and risk of benign breast disease. Breast Cancer Res Treat. 2016 Oct; 159(3):545-52. PMID: 27604359.
    Citations: 2     Fields:    Translation:Humans
  36. Warner ET, Hu R, Collins LC, Beck AH, Schnitt S, Rosner B, Eliassen AH, Michels KB, Willett WC, Tamimi RM. Height and Body Size in Childhood, Adolescence, and Young Adulthood and Breast Cancer Risk According to Molecular Subtype in the Nurses' Health Studies. Cancer Prev Res (Phila). 2016 Sep; 9(9):732-8. PMID: 27590596.
    Citations: 12     Fields:    Translation:Humans
  37. Eliassen AH, Warner ET, Rosner B, Collins LC, Beck AH, Quintana LM, Tamimi RM, Hankinson SE. Plasma 25-Hydroxyvitamin D and Risk of Breast Cancer in Women Followed over 20 Years. Cancer Res. 2016 09 15; 76(18):5423-30. PMID: 27530324.
    Citations: 12     Fields:    Translation:Humans
  38. Collins LC, Schnitt SJ, Tamimi RM. Reply to breast cancer risk by the extent and type of atypical hyperplasia. Cancer. 2016 10; 122(19):3088-9. PMID: 27352006.
    Citations:    Fields:    Translation:Humans
  39. Tung N, Garber JE, Hacker MR, Torous V, Freeman GJ, Poles E, Rodig S, Alexander B, Lee L, Collins LC, Schnitt SJ. Prevalence and predictors of androgen receptor and programmed death-ligand 1 in BRCA1-associated and sporadic triple-negative breast cancer. NPJ Breast Cancer. 2016; 2:16002. PMID: 28721372.
    Citations: 7     
  40. Sisti JS, Collins LC, Beck AH, Tamimi RM, Rosner BA, Eliassen AH. Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies. Int J Cancer. 2016 May 15; 138(10):2346-56. PMID: 26684063.
    Citations: 37     Fields:    Translation:HumansPHPublic Health
  41. Collins LC, Tan PH, Tse GM. Annual Review Issue: Breast Pathology. Histopathology. 2016 Jan; 68(1):3-4. PMID: 26768025.
    Citations:    Fields:    Translation:Humans
  42. Calhoun BC, Collins LC. Recommendations for excision following core needle biopsy of the breast: a contemporary evaluation of the literature. Histopathology. 2016 Jan; 68(1):138-51. PMID: 26768035.
    Citations: 8     Fields:    Translation:Humans
  43. Motzer RJ, Alyasova A, Ye D, Karpenko A, Li H, Alekseev B, Xie L, Kurteva G, Kowalyszyn R, Karyakin O, Neron Y, Cosgriff T, Collins L, Brechenmacher T, Lin C, Morgan L, Yang L. Phase II trial of second-line everolimus in patients with metastatic renal cell carcinoma (RECORD-4). Ann Oncol. 2016 Mar; 27(3):441-8. PMID: 26681676.
    Citations: 12     Fields:    Translation:HumansCTClinical Trials
  44. Collins LC, Aroner SA, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM. Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies. Cancer. 2016 Feb 15; 122(4):515-20. PMID: 26565738.
    Citations: 12     Fields:    Translation:Humans
  45. Ciriello G, Gatza ML, Beck AH, Wilkerson MD, Rhie SK, Pastore A, Zhang H, McLellan M, Yau C, Kandoth C, Bowlby R, Shen H, Hayat S, Fieldhouse R, Lester SC, Tse GM, Factor RE, Collins LC, Allison KH, Chen YY, Jensen K, Johnson NB, Oesterreich S, Mills GB, Cherniack AD, Robertson G, Benz C, Sander C, Laird PW, Hoadley KA, King TA, Perou CM. Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer. Cell. 2015 Oct 08; 163(2):506-19. PMID: 26451490.
    Citations: 525     Fields:    Translation:HumansCells
  46. Wang J, Zhang X, Beck AH, Collins LC, Chen WY, Tamimi RM, Hazra A, Brown M, Rosner B, Hankinson SE. Alcohol Consumption and Risk of Breast Cancer by Tumor Receptor Expression. Horm Cancer. 2015 Dec; 6(5-6):237-46. PMID: 26385458.
    Citations: 6     Fields:    Translation:HumansPHPublic Health
  47. Yaghjyan L, Pettersson A, Colditz GA, Collins LC, Schnitt SJ, Beck AH, Rosner B, Vachon C, Tamimi RM. Postmenopausal mammographic breast density and subsequent breast cancer risk according to selected tissue markers. Br J Cancer. 2015 Sep 29; 113(7):1104-13. PMID: 26335607.
    Citations: 6     Fields:    Translation:Humans
  48. Collins LC, Achacoso N, Haque R, Nekhlyudov L, Quesenberry CP, Schnitt SJ, Habel LA, Fletcher SW. Risk Prediction for Local Breast Cancer Recurrence Among Women with DCIS Treated in a Community Practice: A Nested, Case-Control Study. Ann Surg Oncol. 2015 Dec; 22 Suppl 3:S502-8. PMID: 26059650.
    Citations: 12     Fields:    Translation:Humans
  49. Collins LC, Gelber S, Marotti JD, White S, Ruddy K, Brachtel EF, Schapira L, Come SE, Borges VF, Schedin P, Warner E, Wensley T, Tamimi RM, Winer EP, Partridge AH. Molecular Phenotype of Breast Cancer According to Time Since Last Pregnancy in a Large Cohort of Young Women. Oncologist. 2015 Jul; 20(7):713-8. PMID: 26025931.
    Citations: 4     Fields:    Translation:Humans
  50. Oh EY, Collins LC. Keratin Expression Patterns in Stromal Cells of Benign Sclerosing Lesions of the Breast: A Potential Diagnostic Pitfall. Arch Pathol Lab Med. 2015 Sep; 139(9):1143-8. PMID: 25989286.
    Citations:    Fields:    Translation:HumansCells
  51. Zhang X, Eliassen AH, Tamimi RM, Hazra A, Beck AH, Brown M, Collins LC, Rosner B, Hankinson SE. Adult body size and physical activity in relation to risk of breast cancer according to tumor androgen receptor status. Cancer Epidemiol Biomarkers Prev. 2015 Jun; 24(6):962-8. PMID: 25855627.
    Citations: 5     Fields:    Translation:Humans
  52. Collins L, Okatan MB, Li Q, Kravenchenko II, Lavrik NV, Kalinin SV, Rodriguez BJ, Jesse S. Quantitative 3D-KPFM imaging with simultaneous electrostatic force and force gradient detection. Nanotechnology. 2015 May 01; 26(17):175707. PMID: 25851168.
    Citations: 4     Fields:    
  53. Calhoun BC, Collins LC. Predictive markers in breast cancer: An update on ER and HER2 testing and reporting. Semin Diagn Pathol. 2015 Sep; 32(5):362-9. PMID: 25770732.
    Citations: 24     Fields:    Translation:Humans
  54. Su X, Boeke CE, Collins LC, Baer HJ, Willett WC, Schnitt SJ, Connolly JL, Rosner B, Colditz GA, Tamimi RM. Intakes of fat and micronutrients between ages 13 and 18 years and the incidence of proliferative benign breast disease. Cancer Causes Control. 2015 Jan; 26(1):79-90. PMID: 25376828.
    Citations: 1     Fields:    Translation:Humans
  55. Collins LC, Gobbi H, Farshid G. Breast Pathology: SC03-1 DIAGNOSTIC ISSUES IN BREAST CORE NEEDLE BIOPSY. Pathology. 2014 Oct; 46 Suppl 2:S6. PMID: 25188187.
    Citations:    
  56. Healey MA, Hu R, Beck AH, Collins LC, Schnitt SJ, Tamimi RM, Hazra A. Association of H3K9me3 and H3K27me3 repressive histone marks with breast cancer subtypes in the Nurses' Health Study. Breast Cancer Res Treat. 2014 Oct; 147(3):639-51. PMID: 25224916.
    Citations: 19     Fields:    Translation:HumansCells
  57. Sidani S, Collins L, Harbman P, MacMillan K, Reeves S, Hurlock-Chorostecki C, Donald F, Staples P, van Soeren M. Development of a measure to assess healthcare providers' implementation of patient-centered care. Worldviews Evid Based Nurs. 2014 Aug; 11(4):248-57. PMID: 25040329.
    Citations: 3     Fields:    Translation:HumansPHPublic Health
  58. Houssami N, Abraham LA, Onega T, Collins LC, Sprague BL, Hill DA, Miglioretti DL. Accuracy of screening mammography in women with a history of lobular carcinoma in situ or atypical hyperplasia of the breast. Breast Cancer Res Treat. 2014 Jun; 145(3):765-73. PMID: 24800915.
    Citations: 4     Fields:    Translation:Humans
  59. He BJ, Nolte G, Nagata K, Takano D, Yamazaki T, Fujimaki Y, Maeda T, Satoh Y, Heckers S, George MS, Lopes da Silva F, de Munck JC, Van Houdt PJ, Verdaasdonk RM, Ossenblok P, Mullinger K, Bowtell R, Bagshaw AP, Keeser D, Karch S, Segmiller F, Hantschk I, Berman A, Padberg F, Pogarell O, Scharnowski F, Karch S, Hümmer S, Keeser D, Paolini M, Kirsch V, Koller G, Rauchmann B, Kupka M, Blautzik J, Pogarell O, Razavi N, Jann K, Koenig T, Kottlow M, Hauf M, Strik W, Dierks T, Gotman J, Vulliemoz S, Lu Y, Zhang H, Yang L, Worrell G, He B, Gruber O, Piguet C, Hubl D, Homan P, Kindler J, Dierks T, Kim K, Steinhoff U, Wakai R, Koenig T, Kottlow M, Melie-García L, Mucci A, Volpe U, Prinster A, Salvatore M, Galderisi S, Linden DE, Brandeis D, Schroeder CE, Kayser C, Panzeri S, Kleinschmidt A, Ritter P, Walther S, Haueisen J, Lau S, Flemming L, Sonntag H, Maess B, Knösche TR, Lanfer B, Dannhauer M, Wolters CH, Stenroos M, Haueisen J, Wolters C, Aydin U, Lanfer B, Lew S, Lucka F, Ruthotto L, Vorwerk J, Wagner S, Ramon C, Guan C, Ang KK, Chua SG, Kuah WK, Phua KS, Chew E, Zhou H, Chuang KH, Ang BT, Wang C, Zhang H, Yang H, Chin ZY, Yu H, Pan Y, Collins L, Mainsah B, Colwell K, Morton K, Ryan D, Sellers E, Caves K, Throckmorton S, Kübler A, Holz EM, Zickler C, Sellers E, Ryan D, Brown K, Colwell K, Mainsah B, Caves K, Throckmorton S, Collins L, Wennberg R, Ahlfors SP, Grova C, Chowdhury R, Hedrich T, Heers M, Zelmann R, Hall JA, Lina JM, Kobayashi E, Oostendorp T, van Dam P, Oosterhof P, Linnenbank A, Coronel R, van Dessel P, de Bakker J, Rossion B, Jacques C, Witthoft N, Weiner KS, Foster BL, Miller KJ, Hermes D, Parvizi J, Grill-Spector K, Recanzone GH, Murray MM, Haynes JD, Richiardi J, Greicius M, De Lucia M, Müller KR, Formisano E, Smieskova R, Schmidt A, Bendfeldt K, Walter A, Riecher-Rössler A, Borgwardt S, Fusar-Poli P, Eliez S, Schmidt A, Sekihara K, Nagarajan SS, Schoffelen JM, Guggisberg AG, Nolte G, Balazs S, Kermanshahi K, Kiesenhofer W, Binder H, Rattay F, Antal A, Chaieb L, Paulus W, Bodis-Wollner I, Maurer K, Fein G, Camchong J, Johnstone J, Cardenas-Nicolson V, Fiederer LD, Lucka F, Yang S, Vorwerk J, Dümpelmann M, Cosandier-Rimélé D, Schulze-Bonhage A, Aertsen A, Speck O, Wolters CH, Ball T, Fuchs M, Wagner M, Kastner J, Tech R, Dinh C, Haueisen J, Baumgarten D, Hämäläinen MS, Lau S, Vogrin SJ, D'Souza W, Haueisen J, Cook MJ, Custo A, Van De Ville D, Vulliemoz S, Grouiller F, Michel CM, Malmivuo J, Aydin U, Vorwerk J, Küpper P, Heers M, Kugel H, Wellmer J, Kellinghaus C, Scherg M, Rampp S, Wolters C, Storti SF, Boscolo Galazzo I, Del Felice A, Pizzini FB, Arcaro C, Formaggio E, Mai R, Manganotti P, Koessler L, Vignal J, Cecchin T, Colnat-Coulbois S, Vespignani H, Ramantani G, Maillard L, Rektor I, Kuba R, Brázdil M, Chrastina J, Rektorova I, van Mierlo P, Carrette E, Strobbe G, Montes-Restrepo V, Vonck K, Vandenberghe S, Ahmed B, Brodely C, Carlson C, Kuzniecky R, Devinsky O, French J, Thesen T, Bénis D, David O, Lachaux JP, Seigneuret E, Krack P, Fraix V, Chabardès S, Bastin J, Jann K, Gee D, Kilroy E, Cannon T, Wang DJ, Hale JR, Mayhew SD, Przezdzik I, Arvanitis TN, Bagshaw AP, Plomp G, Quairiaux C, Astolfi L, Michel CM, Mayhew SD, Mullinger KJ, Bagshaw AP, Bowtell R, Francis ST, Schouten AC, Campfens SF, van der Kooij H, Koles Z, Lind J, Flor-Henry P, Wirth M, Haase CM, Villeneuve S, Vogel J, Jagust WJ, Kambeitz-Ilankovic L, Simon-Vermot L, Gesierich B, Duering M, Ewers M, Rektorova I, Krajcovicova L, Marecek R, Mikl M, Bracht T, Horn H, Strik W, Federspiel A, Schnell S, Höfle O, Stegmayer K, Wiest R, Dierks T, Müller TJ, Walther S, Surmeli T, Ertem A, Eralp E, Kos IH, Skrandies W, Flüggen S, Klein A, Britz J, Díaz Hernàndez L, Ro T, Michel CM, Lenartowicz A, Lau E, Rodriguez C, Cohen MS, Loo SK, Di Lorenzo G, Pagani M, Monaco L, Daverio A, Giannoudas I, La Porta P, Verardo AR, Niolu C, Fernandez I, Siracusano A, Flor-Henry P, Lind J, Koles Z, Bollmann S, Ghisleni C, O'Gorman R, Poil SS, Klaver P, Michels L, et al. Abstracts of Presentations at the International Conference on Basic and Clinical Multimodal Imaging (BaCI), a Joint Conference of the International Society for Neuroimaging in Psychiatry (ISNIP), the International Society for Functional Source Imaging (ISFSI), the International Society for Bioelectromagnetism (ISBEM), the International Society for Brain Electromagnetic Topography (ISBET), and the EEG and Clinical Neuroscience Society (ECNS), in Geneva, Switzerland, September 5-8, 2013. Clin EEG Neurosci. 2013 Dec 24. PMID: 24368763.
    Citations:    Fields:    
  60. Liu Y, Colditz GA, Rosner B, Berkey CS, Collins LC, Schnitt SJ, Connolly JL, Chen WY, Willett WC, Tamimi RM. Alcohol intake between menarche and first pregnancy: a prospective study of breast cancer risk. J Natl Cancer Inst. 2013 Oct 16; 105(20):1571-8. PMID: 23985142.
    Citations: 28     Fields:    Translation:Humans
  61. Jeselsohn RM, Werner L, Regan MM, Fatima A, Gilmore L, Collins LC, Beck AH, Bailey ST, He HH, Buchwalter G, Brown M, Iglehart JD, Richardson A, Come SE. Digital quantification of gene expression in sequential breast cancer biopsies reveals activation of an immune response. PLoS One. 2013; 8(5):e64225. PMID: 23741308.
    Citations: 8     Fields:    Translation:Humans
  62. Collins LC, Achacoso N, Haque R, Nekhlyudov L, Fletcher SW, Quesenberry CP, Schnitt SJ, Habel LA. Risk factors for non-invasive and invasive local recurrence in patients with ductal carcinoma in situ. Breast Cancer Res Treat. 2013 Jun; 139(2):453-60. PMID: 23624751.
    Citations: 12     Fields:    Translation:Humans
  63. Aroner SA, Collins LC, Connolly JL, Colditz GA, Schnitt SJ, Rosner BA, Hankinson SE, Tamimi RM. Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies. Breast Cancer Res Treat. 2013 May; 139(1):277-85. PMID: 23609472.
    Citations: 8     Fields:    Translation:Humans
  64. Hefti MM, Hu R, Knoblauch NW, Collins LC, Haibe-Kains B, Tamimi RM, Beck AH. Estrogen receptor negative/progesterone receptor positive breast cancer is not a reproducible subtype. Breast Cancer Res. 2013; 15(4):R68. PMID: 23971947.
    Citations: 44     Fields:    Translation:Humans
  65. Kaplan JS, Schnitt SJ, Collins LC, Wang Y, Garber JE, Montgomery K, West RB, Krag K, Fetten K, Lincoln A, Tung NM. Pathologic features and immunophenotype of estrogen receptor-positive breast cancers in BRCA1 mutation carriers. Am J Surg Pathol. 2012 Oct; 36(10):1483-8. PMID: 22613997.
    Citations: 3     Fields:    Translation:Humans
  66. Johnson NB, Collins LC. Less Common Variants and Mimics of DCIS. Surg Pathol Clin. 2012 Sep; 5(3):529-44. PMID: 26838279.
    Citations:    Fields:    
  67. Zhang X, Smith-Warner SA, Collins LC, Rosner B, Willett WC, Hankinson SE. Use of aspirin, other nonsteroidal anti-inflammatory drugs, and acetaminophen and postmenopausal breast cancer incidence. J Clin Oncol. 2012 Oct 01; 30(28):3468-77. PMID: 22927520.
    Citations: 30     Fields:    Translation:Humans
  68. Hurchla MA, Garcia-Gomez A, Hornick MC, Ocio EM, Li A, Blanco JF, Collins L, Kirk CJ, Piwnica-Worms D, Vij R, Tomasson MH, Pandiella A, San Miguel JF, Garayoa M, Weilbaecher KN. The epoxyketone-based proteasome inhibitors carfilzomib and orally bioavailable oprozomib have anti-resorptive and bone-anabolic activity in addition to anti-myeloma effects. Leukemia. 2013 Feb; 27(2):430-40. PMID: 22763387.
    Citations: 43     Fields:    Translation:HumansAnimalsCells
  69. Su X, Colditz GA, Collins LC, Baer HJ, Sampson LA, Willett WC, Berkey CS, Schnitt SJ, Connolly JL, Rosner BA, Tamimi RM. Adolescent intakes of vitamin D and calcium and incidence of proliferative benign breast disease. Breast Cancer Res Treat. 2012 Jul; 134(2):783-91. PMID: 22622809.
    Citations: 7     Fields:    Translation:Humans
  70. Liu Y, Tamimi RM, Berkey CS, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Colditz GA. Intakes of alcohol and folate during adolescence and risk of proliferative benign breast disease. Pediatrics. 2012 May; 129(5):e1192-8. PMID: 22492774.
    Citations: 12     Fields:    Translation:Humans
  71. Nekhlyudov L, Habel LA, Achacoso N, Jung I, Haque R, Collins LC, Schnitt SJ, Quesenberry CP, Fletcher SW. Ten-year risk of diagnostic mammograms and invasive breast procedures after breast-conserving surgery for DCIS. J Natl Cancer Inst. 2012 Apr 18; 104(8):614-21. PMID: 22491230.
    Citations: 2     Fields:    Translation:Humans
  72. Rice MS, Tamimi RM, Connolly JL, Collins LC, Shen D, Pollak MN, Rosner B, Hankinson SE, Tworoger SS. Insulin-like growth factor-1, insulin-like growth factor binding protein-3 and lobule type in the Nurses' Health Study II. Breast Cancer Res. 2012 Mar 13; 14(2):R44. PMID: 22414675.
    Citations: 10     Fields:    Translation:Humans
  73. McPhail S, West-Merker S, Collins L, van Soeren M. Collaborating across agencies and professionals to provide interprofessional practice: a case analysis. J Interprof Care. 2012 May; 26(3):240-1. PMID: 22235756.
    Citations:    Fields:    Translation:Humans
  74. Collins LC, Marotti JD, Gelber S, Cole K, Ruddy K, Kereakoglow S, Brachtel EF, Schapira L, Come SE, Winer EP, Partridge AH. Pathologic features and molecular phenotype by patient age in a large cohort of young women with breast cancer. Breast Cancer Res Treat. 2012 Feb; 131(3):1061-6. PMID: 22080245.
    Citations: 69     Fields:    Translation:Humans
  75. Santagata S, Hu R, Lin NU, Mendillo ML, Collins LC, Hankinson SE, Schnitt SJ, Whitesell L, Tamimi RM, Lindquist S, Ince TA. High levels of nuclear heat-shock factor 1 (HSF1) are associated with poor prognosis in breast cancer. Proc Natl Acad Sci U S A. 2011 Nov 08; 108(45):18378-83. PMID: 22042860.
    Citations: 123     Fields:    Translation:HumansCells
  76. Liu Y, Tamimi RM, Berkey CS, Willett WC, Collins LC, Schnitt SJ, Colditz GA. Adolescent intakes of alcohol and folate and risk of proliferative benign breast disease. J Clin Oncol. 2011 Sep 20; 29(27_suppl):169. PMID: 27958056.
    Citations:    
  77. Pantanowitz L, Valenstein PN, Evans AJ, Kaplan KJ, Pfeifer JD, Wilbur DC, Collins LC, Colgan TJ. Review of the current state of whole slide imaging in pathology. J Pathol Inform. 2011; 2:36. PMID: 21886892.
    Citations: 101     
  78. Tamimi RM, Colditz GA, Hazra A, Baer HJ, Hankinson SE, Rosner B, Marotti J, Connolly JL, Schnitt SJ, Collins LC. Traditional breast cancer risk factors in relation to molecular subtypes of breast cancer. Breast Cancer Res Treat. 2012 Jan; 131(1):159-67. PMID: 21830014.
    Citations: 84     Fields:    Translation:Humans
  79. Yaghjyan L, Colditz GA, Collins LC, Schnitt SJ, Rosner B, Vachon C, Tamimi RM. Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics. J Natl Cancer Inst. 2011 Aug 03; 103(15):1179-89. PMID: 21795664.
    Citations: 67     Fields:    Translation:Humans
  80. Jung MM, Colditz GA, Collins LC, Schnitt SJ, Connolly JL, Tamimi RM. Lifetime physical activity and the incidence of proliferative benign breast disease. Cancer Causes Control. 2011 Sep; 22(9):1297-305. PMID: 21748307.
    Citations: 7     Fields:    Translation:Humans
  81. Holmes MD, Chen WY, Schnitt SJ, Collins L, Colditz GA, Hankinson SE, Tamimi RM. COX-2 expression predicts worse breast cancer prognosis and does not modify the association with aspirin. Breast Cancer Res Treat. 2011 Nov; 130(2):657-62. PMID: 21728052.
    Citations: 43     Fields:    Translation:Humans
  82. Collins LC, Cole KS, Marotti JD, Hu R, Schnitt SJ, Tamimi RM. Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study. Mod Pathol. 2011 Jul; 24(7):924-31. PMID: 21552212.
    Citations: 85     Fields:    Translation:Humans
  83. Liu Y, Tamimi RM, Collins LC, Schnitt SJ, Gilmore HL, Connolly JL, Colditz GA. The association between vascular endothelial growth factor expression in invasive breast cancer and survival varies with intrinsic subtypes and use of adjuvant systemic therapy: results from the Nurses' Health Study. Breast Cancer Res Treat. 2011 Aug; 129(1):175-84. PMID: 21390493.
    Citations: 25     Fields:    Translation:Humans
  84. Hu R, Dawood S, Holmes MD, Collins LC, Schnitt SJ, Cole K, Marotti JD, Hankinson SE, Colditz GA, Tamimi RM. Androgen receptor expression and breast cancer survival in postmenopausal women. Clin Cancer Res. 2011 Apr 01; 17(7):1867-74. PMID: 21325075.
    Citations: 123     Fields:    Translation:Humans
  85. Tamimi RM, Colditz GA, Wang Y, Collins LC, Hu R, Rosner B, Irie HY, Connolly JL, Schnitt SJ. Expression of IGF1R in normal breast tissue and subsequent risk of breast cancer. Breast Cancer Res Treat. 2011 Jul; 128(1):243-50. PMID: 21197570.
    Citations: 23     Fields:    Translation:HumansCells
  86. Alexander BM, Sprott K, Farrow DA, Wang X, D'Andrea AD, Schnitt SJ, Collins LC, Weaver DT, Garber JE. DNA repair protein biomarkers associated with time to recurrence in triple-negative breast cancer. Clin Cancer Res. 2010 Dec 01; 16(23):5796-804. PMID: 21138871.
    Citations: 8     Fields:    Translation:HumansCells
  87. Tung N, Miron A, Schnitt SJ, Gautam S, Fetten K, Kaplan J, Yassin Y, Buraimoh A, Kim JY, Szász AM, Tian R, Wang ZC, Collins LC, Brock J, Krag K, Legare RD, Sgroi D, Ryan PD, Silver DP, Garber JE, Richardson AL. Prevalence and predictors of loss of wild type BRCA1 in estrogen receptor positive and negative BRCA1-associated breast cancers. Breast Cancer Res. 2010; 12(6):R95. PMID: 21080930.
    Citations: 18     Fields:    Translation:HumansCells
  88. Dawood S, Hu R, Homes MD, Collins LC, Schnitt SJ, Connolly J, Colditz GA, Tamimi RM. Defining breast cancer prognosis based on molecular phenotypes: results from a large cohort study. Breast Cancer Res Treat. 2011 Feb; 126(1):185-92. PMID: 20711652.
    Citations: 44     Fields:    Translation:Humans
  89. Aroner SA, Collins LC, Schnitt SJ, Connolly JL, Colditz GA, Tamimi RM. Columnar cell lesions and subsequent breast cancer risk: a nested case-control study. Breast Cancer Res. 2010; 12(4):R61. PMID: 20691043.
    Citations: 13     Fields:    Translation:Humans
  90. Hilson JB, Schnitt SJ, Collins LC. Phenotypic alterations in myoepithelial cells associated with benign sclerosing lesions of the breast. Am J Surg Pathol. 2010 Jun; 34(6):896-900. PMID: 20463570.
    Citations: 3     Fields:    Translation:HumansCells
  91. Haque R, Achacoso NS, Fletcher SW, Nekhlyudov L, Collins LC, Schnitt SJ, Quesenberry CP, Habel LA. Treatment of ductal carcinoma in situ among patients cared for in large integrated health plans. Am J Manag Care. 2010 May; 16(5):351-60. PMID: 20469955.
    Citations: 10     Fields:    Translation:Humans
  92. Su X, Tamimi RM, Collins LC, Baer HJ, Cho E, Sampson L, Willett WC, Schnitt SJ, Connolly JL, Rosner BA, Colditz GA. Intake of fiber and nuts during adolescence and incidence of proliferative benign breast disease. Cancer Causes Control. 2010 Jul; 21(7):1033-46. PMID: 20229245.
    Citations: 24     Fields:    Translation:Humans
  93. Tung N, Wang Y, Collins LC, Kaplan J, Li H, Gelman R, Comander AH, Gallagher B, Fetten K, Krag K, Stoeckert KA, Legare RD, Sgroi D, Ryan PD, Garber JE, Schnitt SJ. Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features. Breast Cancer Res. 2010; 12(1):R12. PMID: 20149218.
    Citations: 33     Fields:    Translation:Humans
  94. Su X, Colditz GA, Willett WC, Collins LC, Schnitt SJ, Connolly JL, Pollak MN, Rosner B, Tamimi RM. Genetic variation and circulating levels of IGF-I and IGFBP-3 in relation to risk of proliferative benign breast disease. Int J Cancer. 2010 Jan 01; 126(1):180-90. PMID: 19551864.
    Citations: 28     Fields:    Translation:Humans
  95. Collins LC, Achacoso N, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, Puligandla B, Alshak NS, Goldstein LC, Gown AM, Schnitt SJ, Habel LA. Relationship between clinical and pathologic features of ductal carcinoma in situ and patient age: an analysis of 657 patients. Am J Surg Pathol. 2009 Dec; 33(12):1802-8. PMID: 19950406.
    Citations: 5     Fields:    Translation:Humans
  96. Habel LA, Achacoso NS, Haque R, Nekhlyudov L, Fletcher SW, Schnitt SJ, Collins LC, Geiger AM, Puligandla B, Acton L, Quesenberry CP. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting. Breast Cancer Res. 2009; 11(6):R85. PMID: 19922614.
    Citations: 13     Fields:    Translation:Humans
  97. Marotti JD, Collins LC, Hu R, Tamimi RM. Estrogen receptor-beta expression in invasive breast cancer in relation to molecular phenotype: results from the Nurses' Health Study. Mod Pathol. 2010 Feb; 23(2):197-204. PMID: 19898422.
    Citations: 40     Fields:    Translation:Humans
  98. Collins LC, Wang Y, Connolly JL, Baer HJ, Hu R, Schnitt SJ, Colditz GA, Tamimi RM. Potential role of tissue microarrays for the study of biomarker expression in benign breast disease and normal breast tissue. Appl Immunohistochem Mol Morphol. 2009 Oct; 17(5):438-41. PMID: 19363445.
    Citations: 5     Fields:    Translation:Humans
  99. Johnson NB, Collins LC. Update on percutaneous needle biopsy of nonmalignant breast lesions. Adv Anat Pathol. 2009 Jul; 16(4):183-95. PMID: 19546607.
    Citations: 9     Fields:    Translation:Animals
  100. Collins LC, Martyniak A, Kandel MJ, Stadler ZK, Masciari S, Miron A, Richardson AL, Schnitt SJ, Garber JE. Basal cytokeratin and epidermal growth factor receptor expression are not predictive of BRCA1 mutation status in women with triple-negative breast cancers. Am J Surg Pathol. 2009 Jul; 33(7):1093-7. PMID: 19390427.
    Citations: 24     Fields:    Translation:Humans
  101. Schnitt SJ and Collins LC. Pathology of Benign Breast Disorders. Diseases of the Breast. 2009; 69-85.
  102. Collins LC. Preface. Surg Pathol Clin. 2009 Jun; 2(2):ix. PMID: 26838330.
    Citations:    Fields:    
  103. Collins LC. Flat Epithelial Atypia of the Breast. Surg Pathol Clin. 2009 Jun; 2(2):263-72. PMID: 26838322.
    Citations:    Fields:    
  104. Comander AH, Gallagher BM, Krag K, Wang Y, Li H, Gelman R, Collins LC, Schnitt SJ, Garber JE, Tung N. Determination of factors predicting for estrogen receptor positive (ER+) breast cancers in BRCA1 mutation carriers. J Clin Oncol. 2009 May 20; 27(15_suppl):11045. PMID: 27963985.
    Citations:    
  105. Nekhlyudov L, Habel LA, Achacoso NS, Jung I, Haque R, Collins LC, Schnitt SJ, Quesenberry CP, Fletcher SW. Adherence to long-term surveillance mammography among women with ductal carcinoma in situ treated with breast-conserving surgery. J Clin Oncol. 2009 Jul 01; 27(19):3211-6. PMID: 19433691.
    Citations: 9     Fields:    Translation:Humans
  106. Baer HJ, Collins LC, Connolly JL, Colditz GA, Schnitt SJ, Tamimi RM. Lobule type and subsequent breast cancer risk: results from the Nurses' Health Studies. Cancer. 2009 Apr 01; 115(7):1404-11. PMID: 19170235.
    Citations: 34     Fields:    Translation:Humans
  107. Collins L, Schnitt S, Achacoso N, Fletcher S, Nekhlyudov L, Haque R, Quesenberry C and Habel L. Outcome of women with ductal carcinoma in situ (DCIS) treated with breast conserving surgery alone: a case-control study of 225 patients from the Cancer Research Network. Mod Pathol. 2009.
  108. Hu R, Dawood S, Collins LC, Schnitt SJ, Cole K, Marotti J, Colditz GA, Tamimi RM. Androgen receptor and breast cancer survival in postmenopausal women. Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2009.
  109. Cole K, Tamimi R, Hu R, Colditz G, Schnitt S and Collins. Relationship Between Molecular Phenotype Of Invasive Breast Cancer And Expression Of Androgen Receptor. Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2009.
  110. Cole K, Tamimi R, Hu R, Colditz G, Schnitt S and Collins. Relationship Between Molecular Phenotype Of Invasive Breast Cancer And Expression Of Androgen Receptor. Mod Pathol. 2009.
  111. Belsley NA, Collins LC, Rice MS, Walker S, Tworoger S and Frank DA. Expression of phospho(p)STAT3 and phospho(p)STAT5 in Breast Cancer and Correlation with Plasma Prolactin Levels. Mod Pathol. 2009.
  112. Cole K, Tamimi R, Hu R, Colditz G, Schnitt S and Collins. Androgen Receptor (AR) Expression In Ductal Carcinoma In Situ (DCIS) And Its Relationship To Molecular Subtype. Mod Pathol. 2009.
  113. Cole K, Tamimi R, Hu R, Colditz G, Schnitt S and Collins. Androgen Receptor (AR) Expression In Ductal Carcinoma In Situ (DCIS) And Its Relationship To Molecular Subtype. Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2009.
  114. Wang Y, Connolly J, Hu R, Baer H, Colditz G, Schnitt S, Collins L and Tamimi R. Expression of Insulin-Like Growth Factor-I Receptor (IGF-IR) in Normal Breast Tissue and Breast Cancer Risk: Results from the Nurses Health Study. Mod Pathol. 2009.
  115. Hilson JB, Schnitt SJ, Collins LC. Phenotypic alterations in ductal carcinoma in situ-associated myoepithelial cells: biologic and diagnostic implications. Am J Surg Pathol. 2009 Feb; 33(2):227-32. PMID: 18936688.
    Citations: 21     Fields:    Translation:HumansCells
  116. Laura Collins, Editor. Surgical Pathology Clinics. Breast Pathology. 2008; In press.
  117. Tamimi RM, Schnitt SJ, Colditz GA, Collins LC. Luminal B breast tumors are not HER2 positive - authors' response. Breast Cancer Res. 2008; 10(5):405.
  118. SJ Schnitt and LC Collins. Breast Biopsy Interpretation. 2008.
  119. Kleer CG, Bloushtain-Qimron N, Chen YH, Carrasco D, Hu M, Yao J, Kraeft SK, Collins LC, Sabel MS, Argani P, Gelman R, Schnitt SJ, Krop IE, Polyak K. Epithelial and stromal cathepsin K and CXCL14 expression in breast tumor progression. Clin Cancer Res. 2008 Sep 01; 14(17):5357-67. PMID: 18765527.
    Citations: 38     Fields:    Translation:HumansCells
  120. Tamimi RM, Baer HJ, Marotti J, Galan M, Galaburda L, Fu Y, Deitz AC, Connolly JL, Schnitt SJ, Colditz GA, Collins LC. Comparison of molecular phenotypes of ductal carcinoma in situ and invasive breast cancer. Breast Cancer Res. 2008; 10(4):R67. PMID: 18681955.
    Citations: 121     Fields:    Translation:Humans
  121. Alexander B, Sprott K, Weaver D, D’Andrea A, Schnitt S, Collins L, Garber J. DNA Repair Antibodies as Predictive and Prognostic Biomarkers in Triple Negative Breast Cancer. Presented at the 5th Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2008.
  122. Wang Y, Collins L, Schnitt S, Garber J and Tung N. Characterization of Estrogen Receptor Positive Breast Cancers in BRCA1 Mutation Carriers. Presented at the 5th Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2008.
  123. Collins LC, Marotti JD, Baer HJ, Tamimi RM. Comparison of estrogen receptor results from pathology reports with results from central laboratory testing. J Natl Cancer Inst. 2008 Feb 06; 100(3):218-21. PMID: 18230800.
    Citations: 41     Fields:    Translation:Humans
  124. Gilmore HL, Collins LC, Connolly JL, Schnitt SJ. Impact of the New American Society of Clinical Oncology (ASCO)/College of American Pathologists (CAP) Guidelines on the Determination of Breast Cancer HER2 Status . Mod Pathol. 2008.
  125. Turner MS, Wang HH, Beasley MB, Collins LC, Folpe AL, Hecht JL, Hunt JL, van de Rijn M, Goldsmith JD. Non-Gastrointestinal Pathologists Are Highly Reproducible in Their Diagnosis of Serrated Polyps of the Colorectum Following Tutorial Instruction . Mod Pathol. 2008.
  126. Baer H, Collins L, Connolly J, Colditz G, Schnitt S, Tamimi R. Lobular Involution and Subsequent Breast Cancer Risk: Findings from the Nurses Health Studies. Mod Pathol. 2008.
  127. Hilson JB, Schnitt SJ, Collins LC. Phenotypic Profile of Myoepithelial Cells (MEC) in Benign Sclerosing Lesions and Ductal Carcinoma In Situ (DCIS: Diagnostic Implications . Mod Pathol. 2008.
  128. Espinosa I, Collins LC, West RB, Schnitt SJ, van de Rijn M. Periostin (POSTN, OSF2) Expression in Stroma of Normal Breast Tissue and Pre-Invasive Breast Lesions . Mod Pathol. 2008.
  129. Collins LC, Schnitt SJ. Papillary lesions of the breast: selected diagnostic and management issues. Histopathology. 2008 Jan; 52(1):20-9. PMID: 18171414.
    Citations: 39     Fields:    Translation:Humans
  130. Wang Y, Collins L, Schnitt S, Garber J, Tung N. Characterization of Estrogen Receptor Positive Breast Cancers in BRCA1 Mutation Carriers . Mod Pathol. 2008.
  131. Marotti J, Tamimi R, Baer H, Connolly J, Colditz G, Schnitt S, Collins L. Expression of Estrogen Receptor Beta in Invasive Breast Cancers in Relation to Molecular Phenotype. Mod Pathol. 2008.
  132. Marotti J, Tamimi R, Baer H, Connolly J, Colditz G, Schnitt S, Collins L. Comparison of Estrogen Receptor and Progesterone Receptor Assay Results from Pathology Reports with Results from Centralized Testing: Implications for Population-Based Studies . Mod Pathol. 2008.
  133. Collins LC, Achacoso NA, Nekhlyudov L, Fletcher SW, Haque R, Quesenberry CP, Alshak NS, Puligandla B, Brodsky GL, Schnitt SJ, Habel LA. Clinical and pathologic features of ductal carcinoma in situ associated with the presence of flat epithelial atypia: an analysis of 543 patients. Mod Pathol. 2007 Nov; 20(11):1149-55. PMID: 17767135.
    Citations: 10     Fields:    Translation:Humans
  134. Masciari S, Larsson N, Senz J, Boyd N, Kaurah P, Kandel MJ, Harris LN, Pinheiro HC, Troussard A, Miron P, Tung N, Oliveira C, Collins L, Schnitt S, Garber JE, Huntsman D. Germline E-cadherin mutations in familial lobular breast cancer. J Med Genet. 2007 Nov; 44(11):726-31. PMID: 17660459.
    Citations: 41     Fields:    Translation:HumansCells
  135. Collins LC, Martyniak A, Kandel MJ, Stadler Z, Masciari S, Harris L, Miron A, Richardson A, Schnitt SJ and Garber JE. Is Basal Cytokeratin (CK) or Epidermal Growth Factor Receptor (EGFR) Expression Predictive of BRCA1 Mutation Status in Women with Triple Negative Breast Cancers? . Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2007.
  136. Hilson JB, Schnitt SJ and Collins LC. Phenotypic Alterations in Ductal Carcinoma in Situ-Associated Myoepithelial Cells: Biological and Diagnostic Implications. Mod Pathol. 2007; 20:36A.
  137. Martyniak A, Kandel MJ, Stadler Z, Masciari S, Harris L, Miron A, Richardson A, Schnitt SJ, Garber JE and Collins LC. Is Basal Cytokeratin (CK) or Epidermal Growth Factor Receptor (EGFR) Expression Predictive of BRCA1 Mutation Status in Women with Triple Negative Breast Cancers? . Mod Pathol. 2007; 20:41A.
  138. Alexander BM, Bryan B, Collins LC, Recht A. Atypical cytology in a persistent seroma following mastectomy for breast cancer: a case report and review of the literature. Breast J. 2007 Mar-Apr; 13(2):196-9. PMID: 17319864.
    Citations:    Fields:    Translation:HumansCells
  139. Galaburda LS, Tamimi RM, Baer HJ, Dietz AC, Colditz GA, Schnitt SJand Collins LC. Are The Different Molecularly-Defined Subtypes Of Invasive Breast Cancer Associated With Different Reproductive Risk Factors?. Mod Pathol. 2007; 20:31A.
  140. Galan MA,Tamimi RM, Baer HJ, Deitz AC, Colditz GA, Schnitt SJ and Collins LC. Comparison of the Prevalence of Molecular Phenotypes in DCIS and Invasive Breast Cancer: A Tissue Microarray-Based Analysis of 977 Cases. Mod Pathol. 2007; 20:31A.
  141. Zhu T, Guo J, Collins L, Kelly J, Xiao ZJ, Kim SH, Chen CY. Phellinus linteus activates different pathways to induce apoptosis in prostate cancer cells. Br J Cancer. 2007 Feb 26; 96(4):583-90. PMID: 17262078.
    Citations: 13     Fields:    Translation:HumansAnimalsCells
  142. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. Magnitude and laterality of breast cancer risk according to histologic type of atypical hyperplasia: results from the Nurses' Health Study. Cancer. 2007 Jan 15; 109(2):180-7. PMID: 17154175.
    Citations: 37     Fields:    Translation:Humans
  143. Collins L, Schnitt SJ, Colditz GA, Dietz A, Baer HJ, Connolly JL, Rubin M, Fu Y, Rosner B, Tamimi RM. Risk Factors for Luminal, HER2, and Basal-like Breast Cancer Sub-types: Results from a Tissue Microarray-Based Analysis of 3167 Breast Cancers from Women Enrolled in the Nurses’ Health Study. San Antonio Breast Cancer Symposium. 2006.
  144. Collins LC, Martyniak A, Kandel MJ, Stadler Z, Masciari S, Harris L, Miron A, Richardson A, Schnitt SJ, Garber JE. Correlation of BRCA 1 Mutation Status with Basal Cytokeratin and Epidermal Growth Factor Receptor Expression in Women with “Triple Negative” Breast Cancers. San Antonio Breast Cancer Symposium. 2006.
  145. Collins LC, Baer HJ, Tamimi RM, Connolly JL, Colditz GA, Schnitt SJ. The influence of family history on breast cancer risk in women with biopsy-confirmed benign breast disease: results from the Nurses' Health Study. Cancer. 2006 Sep 15; 107(6):1240-7. PMID: 16902983.
    Citations: 32     Fields:    Translation:Humans
  146. Collins LC, Carlo VP, Hwang H, Barry TS, Gown AM, Schnitt SJ. Intracystic papillary carcinomas of the breast: a reevaluation using a panel of myoepithelial cell markers. Am J Surg Pathol. 2006 Aug; 30(8):1002-7. PMID: 16861972.
    Citations: 28     Fields:    Translation:HumansCells
  147. Collins L, Zhu T, Guo J, Xiao ZJ, Chen CY. Phellinus linteus sensitises apoptosis induced by doxorubicin in prostate cancer. Br J Cancer. 2006 Aug 07; 95(3):282-8. PMID: 16868541.
    Citations: 12     Fields:    Translation:HumansAnimalsCells
  148. Kandel MJ, Stadler Z, Masciari S, Collins L, Schnitt S, Harris L, Miron A, Richardson A, Garber JE. Prevalence of BRCA1 mutations in triple negative breast cancer (BC). J Clin Oncol. 2006 Jun 20; 24(18_suppl):508. PMID: 27953622.
    Citations:    
  149. Upalakalin JN, Collins LC, Tawa N, Parangi S. Carcinoid tumors in the breast. Am J Surg. 2006 Jun; 191(6):799-805. PMID: 16720153.
    Citations: 21     Fields:    Translation:Humans
  150. Bryan BB, Schnitt SJ, Collins LC. Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer. Mod Pathol. 2006 May; 19(5):617-21. PMID: 16528377.
    Citations: 57     Fields:    Translation:Humans
  151. O'Malley FP, Mohsin SK, Badve S, Bose S, Collins LC, Ennis M, Kleer CG, Pinder SE, Schnitt SJ. Interobserver reproducibility in the diagnosis of flat epithelial atypia of the breast. Mod Pathol. 2006 Feb; 19(2):172-9. PMID: 16424892.
    Citations: 17     Fields:    Translation:HumansCells
  152. Schnitt SJ and Collins LC. Columnar Cell Lesions and Flat Epithelial Atypia of the Breast. Seminars in Diagnostic Pathology. 2006.
  153. Gilmore H, Tamimi R, Baer H, Connolly J, Colditz, Schnitt and Collins L. Immunophenotype of Invasive Breast Cancers in Women with Prior Biopsy-Confirmed Benign Breast Disease: Results from the Nurses’ Health Study. Lab Invest. 2006.
  154. Kandel MJ, Stadler Z, Masciari S, Collins L, Schnitt S, Harris L, Miron A, Richardson A, Garber JE. Prevalence of BRCA1 Mutations in Triple Negative Breast Cancer. ASCO Meeting. 2006.
  155. Habel LA, Achacoso NS, Nekhlyudov L, Haque R, Schnitt S, Collins L, Acton LL, Fletcher S, Quesenberry CP. Declining recurrence rates among DCIS patients treated with breast-conserving surgery in the community setting . San Antonio Breast Cancer Symposium. 2006.
  156. Kraeft S, Collins L, and Schnitt S. The Protease Cathepsin K is Highly Expressed in the Stroma of Human Breast Cancers. Lab Invest. 2006.
  157. Collins L, Baer H, Tamimi R, Connolly J, Colditz G and Schnitt S. Magnitude and Laterality of Breast Cancer Risk in Women with Atypical Hyperplasia of Ductal and Lobular Types. Lab Invest. 2006.
  158. Collins L, Baer H, Tamimi R, Connolly J, Colditz G and Schnitt S. The Effect of a Positive Family History on Breast Cancer Risk in Women with Prior Benign Breast Disease. Lab Invest. 2006.
  159. Hu J, Zhang X, Dong X, Collins L, Sawyer GJ, Fabre JW. A remarkable permeability of canalicular tight junctions might facilitate retrograde, non-viral gene delivery to the liver via the bile duct. Gut. 2005 Oct; 54(10):1473-9. PMID: 15985562.
    Citations: 5     Fields:    Translation:AnimalsCells
  160. Spurgeon S, Garzotto M, Collins L, Priest R, Hsieh YC, Peters L, Beer TM, Mori M. Utility of PSA doubling time (PSADT) in the detection of prostate cancer in men with a serum PSA = 10 ng/ml. J Clin Oncol. 2005 Jun; 23(16_suppl):4645. PMID: 27947022.
    Citations:    
  161. Garzotto M, Collins L, Priest R, Spurgeon S, Hsieh YC, Beer TM, Mori M. Nomogram for the prediction of high-grade prostate cancer on ultrasound-guided needle biopsy. J Clin Oncol. 2005 Jun; 23(16_suppl):4621. PMID: 27947007.
    Citations:    
  162. Collins LC, Schnitt SJ. HER2 protein overexpression in estrogen receptor-positive ductal carcinoma in situ of the breast: frequency and implications for tamoxifen therapy. Mod Pathol. 2005 May; 18(5):615-20. PMID: 15696127.
    Citations: 13     Fields:    Translation:Humans
  163. Kurian AW, Mills MA, Jaffee M, Sigal BM, Chun NM, Kingham KE, Collins LC, Nowels KW, Plevritis SK, Garber JE, Ford JM, Hartman AR. Ductal lavage of fluid-yielding and non-fluid-yielding ducts in BRCA1 and BRCA2 mutation carriers and other women at high inherited breast cancer risk. Cancer Epidemiol Biomarkers Prev. 2005 May; 14(5):1082-9. PMID: 15894656.
    Citations: 7     Fields:    Translation:Humans
  164. Collins LC, Tamimi RM, Baer HJ, Connolly JL, Colditz GA, Schnitt SJ. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study. Cancer. 2005 May 01; 103(9):1778-84. PMID: 15770688.
    Citations: 73     Fields:    Translation:HumansCells
  165. Collins LC, Botero ML, Schnitt SJ. Bimodal frequency distribution of estrogen receptor immunohistochemical staining results in breast cancer: an analysis of 825 cases. Am J Clin Pathol. 2005 Jan; 123(1):16-20. PMID: 15762275.
    Citations: 40     Fields:    Translation:Humans
  166. Collins L, Baer H, Tamimi R, Connolly J, Colditz G, Schnitt S. Influence of Family History on Breast Cancer Risk in Women with Biopsy-Confirmed Benign Breast Disease: Results from the Nurses’ Health Study. Presented at the 2nd Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2005.
  167. Collins L, Rubin M, Schnitt S. Potential Role for Tissue Microarrays for the Study of Biomarker Expression in Benign Breast Disease and Normal Breast Tissue. Presented at the 2nd Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2005.
  168. Collins L, Carlo VP, Hwang H, Barry T, Yaziji H, Gown AM, Schnitt SJ. . Are So-Called “Intracystic” Papillary Carcinomas Of The Breast In Situ Or Invasive Lesions?. Breast Cancer Res Treat. 2005; 94(suppl 1):2023A.
  169. Collins L, Baer H, Tamimi R, Connolly J, Colditz G, Schnitt S. Magnitude and Laterality of Breast Cancer Risk in According to Histological Type of Atypical Hyperplasia: Results from the Nurses’ Health Study. Breast Cancer Res Treat. 2005; 94(suppl 1):27A.
  170. Kraeft S, Collins L, Sneddon J, Brown P, van de Rijn M, Schnitt S. Stromal Cells of Some Pre-Invasive Breast Lesions Exhibit Biological Attributes of Stromal Cells Associated With Breast Cancers. Lab Invest. 2005; 85(suppl 1):38A.
  171. Kraeft S, Collins L, Sneddon J, Brown P, van de Rijn M, Schnitt S. Stromal Cells of Some Pre-Invasive Breast Lesions Exhibit Biological Attributes of Stromal Cells Associated With Breast Cancers. Presented at the 2nd Symposium of the Dana-Farber/Harvard Cancer Center Program in Breast Cancer. 2005.
  172. O’ Malley F, Badve S, Bose S, Collins L, Ennis M, Kleer C, Mohsin S, Pinder S, Schnitt S. How Reproducible is the Diagnosis of Flat Epithelial Atypia of the Breast?. Lab Invest. 2005; 85(suppl 1):46A.
  173. Bryan B, Schnitt S, Collins L. Is There a Ductal Carcinoma in Situ (DCIS) Counterpart to Invasive Basal-like Breast Cancers?. Lab Invest. 2005; 85(suppl 1):28A.
  174. Collins L, Baer H, Tamimi R, Connolly J, Colditz G, Schnitt S. Influence of Family History on Breast Cancer Risk in Women with Biopsy-Confirmed Benign Breast Disease: Results from the Nurses’ Health Study. Breast Cancer Res Treat. 2005; 94(suppl 1):6006A.
  175. Collins LC, Schnitt SJ . The Breast. Mills, SE, ed. Histology for Pathologists. 2005.
  176. Collins L, Rubin M, Schnitt S. Potential Role for Tissue Microarrays for the Study of Biomarker Expression in Benign Breast Disease and Normal Breast Tissue. Lab Invest. 2005; 85(suppl 1):30A.
  177. Collins L, Rubin M, Schnitt S. Are Tissue Microarrays Useful For the Study of Preinvasive Breast Lesions?. Breast Cancer Res Treat. 2004; 88(suppl 1):5023A.
  178. Collins LC, Connolly JL, Page DL, Goulart RA, Pisano ED, Fajardo LL, Berg WA, Caudry DJ, McNeil BJ, Schnitt SJ. Diagnostic agreement in the evaluation of image-guided breast core needle biopsies: results from a randomized clinical trial. Am J Surg Pathol. 2004 Jan; 28(1):126-31. PMID: 14707874.
    Citations: 15     Fields:    Translation:HumansCTClinical Trials
  179. Creighton S, Almqvist EW, MacGregor D, Fernandez B, Hogg H, Beis J, Welch JP, Riddell C, Lokkesmoe R, Khalifa M, MacKenzie J, Sajoo A, Farrell S, Robert F, Shugar A, Summers A, Meschino W, Allingham-Hawkins D, Chiu T, Hunter A, Allanson J, Hare H, Schween J, Collins L, Sanders S, Greenberg C, Cardwell S, Lemire E, MacLeod P, Hayden MR. Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. Clin Genet. 2003 Jun; 63(6):462-75. PMID: 12786753.
    Citations: 44     Fields:    Translation:HumansCells
  180. Zhang X, Collins L, Sawyer GJ, Dong X, Qiu Y, Fabre JW. In vivo gene delivery via portal vein and bile duct to individual lobes of the rat liver using a polylysine-based nonviral DNA vector in combination with chloroquine. Hum Gene Ther. 2001 Dec 10; 12(18):2179-90. PMID: 11779402.
    Citations: 10     Fields:    Translation:HumansAnimalsCells
  181. Zhang X, Collins L, Fabre JW. A powerful cooperative interaction between a fusogenic peptide and lipofectamine for the enhancement of receptor-targeted, non-viral gene delivery via integrin receptors. J Gene Med. 2001 Nov-Dec; 3(6):560-8. PMID: 11778902.
    Citations: 6     Fields:    Translation:HumansCells
  182. Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, Woods R, Paus T, Simpson G, Pike B, Holmes C, Collins L, Thompson P, MacDonald D, Iacoboni M, Schormann T, Amunts K, Palomero-Gallagher N, Geyer S, Parsons L, Narr K, Kabani N, Le Goualher G, Feidler J, Smith K, Boomsma D, Hulshoff Pol H, Cannon T, Kawashima R, Mazoyer B. A four-dimensional probabilistic atlas of the human brain. J Am Med Inform Assoc. 2001 Sep-Oct; 8(5):401-30. PMID: 11522763.
    Citations: 104     Fields:    Translation:Humans
  183. Mazziotta J, Toga A, Evans A, Fox P, Lancaster J, Zilles K, Woods R, Paus T, Simpson G, Pike B, Holmes C, Collins L, Thompson P, MacDonald D, Iacoboni M, Schormann T, Amunts K, Palomero-Gallagher N, Geyer S, Parsons L, Narr K, Kabani N, Le Goualher G, Boomsma D, Cannon T, Kawashima R, Mazoyer B. A probabilistic atlas and reference system for the human brain: International Consortium for Brain Mapping (ICBM). Philos Trans R Soc Lond B Biol Sci. 2001 Aug 29; 356(1412):1293-322. PMID: 11545704.
    Citations: 727     Fields:    Translation:Humans
  184. Patel S, Zhang X, Collins L, Fabre JW. A small, synthetic peptide for gene delivery via the serpin-enzyme complex receptor. J Gene Med. 2001 May-Jun; 3(3):271-9. PMID: 11437332.
    Citations: 2     Fields:    Translation:Cells
  185. Yu J, Wang Y, Soukhova G, Collins LC, Falcone JC. Excitatory lung reflex may stress inspiratory muscle by suppressing expiratory muscle activity. J Appl Physiol (1985). 2001 Mar; 90(3):857-64. PMID: 11181593.
    Citations: 1     Fields:    Translation:Animals
  186. Collins LC, Niloff J, Burke L, Abu-Jawdeh G, Wang H. Relative risk of high grade squamous intraepithelial lesion associated with prior abnormal Pap smears. J Reprod Med. 2001 Feb; 46(2):105-9. PMID: 11255808.
    Citations:    Fields:    Translation:HumansPHPublic Health
  187. Li J, Collins L, Zhang X, Gustafsson K, Fabre JW. Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection. Transplant Proc. 2001 Feb-Mar; 33(1-2):589. PMID: 11266971.
    Citations: 1     Fields:    Translation:HumansAnimals
  188. Li JM, Collins L, Zhang X, Gustafsson K, Fabre JW. Efficient gene delivery to vascular smooth muscle cells using a nontoxic, synthetic peptide vector system targeted to membrane integrins: a first step toward the gene therapy of chronic rejection. Transplantation. 2000 Dec 15; 70(11):1616-24. PMID: 11152225.
    Citations: 2     Fields:    Translation:HumansAnimals
  189. Collins L, Sawyer GJ, Zhang XH, Gustafsson K, Fabre JW. In vitro investigation of factors important for the delivery of an integrin-targeted nonviral DNA vector in organ transplantation. Transplantation. 2000 Mar 27; 69(6):1168-76. PMID: 10762223.
    Citations: 2     Fields:    Translation:HumansCells
  190. Jung I, Reeder JE, Cox C, Siddiqui JF, O'Connell MJ, Collins L, Yang Z, Messing EM, Wheeless LL. Chromosome 9 monosomy by fluorescence in situ hybridization of bladder irrigation specimens is predictive of tumor recurrence. J Urol. 1999 Dec; 162(6):1900-3. PMID: 10569533.
    Citations: 3     Fields:    Translation:HumansCellsCTClinical Trials
  191. Hetelekidis S, Collins L, Silver B, Manola J, Gelman R, Cooper A, Lester S, Lyons JA, Harris JR, Schnitt SJ. Predictors of local recurrence following excision alone for ductal carcinoma in situ. Cancer. 1999 Jan 15; 85(2):427-31. PMID: 10023711.
    Citations: 10     Fields:    Translation:Humans
  192. Abner AL, Collins L, Peiro G, Recht A, Come S, Shulman LN, Silver B, Nixon A, Harris JR, Schnitt SJ, Connolly JL. Correlation of tumor size and axillary lymph node involvement with prognosis in patients with T1 breast carcinoma. Cancer. 1998 Dec 15; 83(12):2502-8. PMID: 9874455.
    Citations: 13     Fields:    Translation:Humans
  193. Collins LC, Wang HH, Abu-Jawdeh GM. Qualifiers of atypical squamous cells of undetermined significance help in patient management. Mod Pathol. 1996 Jun; 9(6):677-81. PMID: 8782207.
    Citations: 2     Fields:    Translation:Humans
  194. Malanoski GJ, Collins L, Wennersten C, Moellering RC, Eliopoulos GM. In vitro activity of biapenem against clinical isolates of gram-positive and gram-negative bacteria. Antimicrob Agents Chemother. 1993 Sep; 37(9):2009-16. PMID: 8239623.
    Citations: 8     Fields:    Translation:HumansCells
  195. Rudd MA, George D, Johnstone MT, Moore RT, Collins L, Rabbani LE, Loscalzo J. Effect of thrombin inhibition on the dynamics of thrombolysis and on platelet function during thrombolytic therapy. Circ Res. 1992 Apr; 70(4):829-34. PMID: 1551206.
    Citations: 5     Fields:    Translation:AnimalsCells
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For faculty or fellow appointment updates and changes, please ask your appointing department to contact HMS. For fellow personal and demographic information, contact HMS Human Resources at human_resourceshms.harvard.edu. For faculty personal and demographic information, contact HMS Office for Faculty Affairs at facappthms.harvard.edu.
Collins's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (439)
Explore
_
Co-Authors (103)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Physical Neighbors
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.